How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Serum Separator Tubes Market
- By Tube Material: Glass Serum Separator Tubes, Plastic Serum Separator Tubes
- By Tube Size: 2 mL, 3 mL, 4 mL, 5 mL, 7 mL
- By Additive Type: Gel Separator, Clot Activator, Heparin, EDTA
- By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Research Laboratories
- By Application: Clinical Chemistry, Immunology, Serology, Hematology
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Glass Serum Separator Tubes leads By Tube Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Serum Separator Tubes Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Tube Material 2
Tube Size 5
Additive Type 4
End User 4
Application 4
Companies profiled
BD (Becton
Dickinson and Company)
Greiner Bio-One International GmbH
Terumo Corporation
Sartorius AG
Sarstedt AG & Co. KG
Nipro Corporation
Kangjian Medical Apparatus Co. Ltd.
Jiangsu Kangjian Medical Apparatus Co. Ltd.
Ningbo Medical Needle Co. Ltd.
Vacuette (Greiner Bio-One)
Hettich Lab Technology
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BD (Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Dickinson and Company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Sarstedt AG & Co. KG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Kangjian Medical Apparatus Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Jiangsu Kangjian Medical Apparatus Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Ningbo Medical Needle Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Vacuette (Greiner Bio-One)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Hettich Lab Technology
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Biosigma S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Ningbo Kangjian Medical Apparatus Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,019M by 2033 · 10.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Glass Serum Separator Tubes84.6
- Plastic Serum Separator Tubes15.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$294.2M → $681.9M · 11.1%
Europe$205.0M → $490.3M · 11.5%
Asia Pacific$187.2M → $440.5M · 11.3%
Latin America$115.9M → $280.9M · 11.7%
Middle East and Africa$89.2M → $206.7M · 11.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.722026
10.722027
10.732028
10.742029
10.762030
10.772031
10.792032
10.792033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BD (Becton30.6
- Dickinson and Company)12.4
- Greiner Bio-One International GmbH5.6
- Terumo Corporation5.2
- Sartorius AG13.0
- Sarstedt AG & Co. KG5.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Tube Material23.1%
Tube Size22.1%
Additive Type19.3%
End User15.2%
Application20.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.5
- Europe23.3
- Asia Pacific21.0
- Latin America13.4
- Middle East and Africa9.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BD (Becton | 89 | 75 | 96 | 82 | 82 | 97 | 87 |
| Dickinson and Company) | 73 | 68 | 73 | 91 | 83 | 86 | 79 |
| Greiner Bio-One International GmbH | 72 | 76 | 63 | 86 | 87 | 76 | 77 |
| Terumo Corporation | 74 | 57 | 75 | 78 | 61 | 68 | 69 |
| Sartorius AG | 77 | 62 | 56 | 56 | 56 | 62 | 62 |
| Sarstedt AG & Co. KG | 59 | 66 | 60 | 48 | 52 | 65 | 58 |
| Nipro Corporation | 45 | 66 | 64 | 53 | 51 | 47 | 54 |
| Kangjian Medical Apparatus Co. Ltd. | 45 | 47 | 39 | 49 | 35 | 42 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BD (Becton
- Dickinson and Company)
- Greiner Bio-One International GmbH
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BD (Becton | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Dickinson and Company) | ✓ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Greiner Bio-One International GmbH | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Terumo Corporation | ◐ | − | ✓ | ◐ | − | − |
| Sartorius AG | ◐ | − | − | ◐ | − | − |
| Sarstedt AG & Co. KG | − | ◐ | − | − | − | ◐ |
| Nipro Corporation | − | ✓ | ◐ | ◐ | − | − |
| Kangjian Medical Apparatus Co. Ltd. | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BD (Becton87
2Dickinson and Company)79
3Greiner Bio-One International GmbH77
4Terumo Corporation69
5Sartorius AG62
6Sarstedt AG & Co. KG58
7Nipro Corporation54
8Kangjian Medical Apparatus Co. Ltd.43
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BD (BectonDickinson and Company)
Challenger2
Strong scale, closing on the leaders.
Greiner Bio-One International GmbHTerumo Corporation
Contender2
Focused players with pockets of strength.
Sartorius AGSarstedt AG & Co. KG
Niche2
Specialists in a single segment or region.
Nipro CorporationKangjian Medical Apparatus Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Tube Material in North America, then scale across Serum Separator Tubes Market — a $194M beachhead inside a $2.64B market.
Beachhead (SOM)$194Mobtainable near-term
Serviceable (SAM)$1.08Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Glass Serum Separator Tubes
Best fit — highest urgency & budget in Tube Material.
Economic buyer75 fit
Plastic Serum Separator Tubes
Strong fit — clear ROI and a fast path to value.
End user64 fit
Enterprise buyers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Tube Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Tube Size & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Additive Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales48%
Partner / channel25%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Tube Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Serum Separator Tubes Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified26%
Evaluation13%
Closed-won7%
$13.3KCAC
$66KLTV
5.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Serum Separator Tubes Market is a resilient opportunity — $3.21B by 2033, compounding at 5.1%.
TAM · 2025$2.15Btoday
TAM · 2033$3.21Bforecast
CAGR5.1%2027–2033
Cumulative$23.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.21BTotal addressable market
SAM$1.18BServiceable available market
SOM$227MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.1% CAGR
Demand compounds through 2033, outpacing GDP across Tube Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Tube Material moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.21BLarge & growingTAM by 2033 at 5.1% CAGR
$1.18BServiceable nowreachable with today’s model
$227MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.50BBear3.3% CAGR
$3.21BBase5.1% CAGR
$4.10BBull6.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Tube Size optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Serum Separator Tubes Market — a $6.41B market by 2033. Plan: grow share from 11.6% to 18.0%.
Market size · 2033$6.41Btotal addressable
Market CAGR7.6%2027–2033
Target share18.0%from 11.6% today
Revenue ambition$1.15Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.6% | 18.0% | At risk |
| Revenue | $709M | $1.15B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 34.8% | 43.0% | On track |
| Customer retention | 90.5% | 93.2% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Tube Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Tube Size capability
A defensible second engine — invest in Tube Size to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Tube Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Tube Size
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $163M capacity & capability investment
- Greenlight bolt-on M&A in Tube Size
- Authorise North America expansion plan
- Fund R&D program for Tube Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Serum Separator Tubes Market conversation — a $8.11B market you can size, segment and defend in minutes.
Market size · 2033$8.11Btotal opportunity
Growth5.3%CAGR to 2033
Addressable buyers1,156+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Tube Material
Goal Grow share in Tube Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 3 mopayback period
$45K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
BD (BectonDickinson and Company)Greiner Bio-One International GmbHTerumo CorporationSartorius AGSarstedt AG & Co. KGNipro CorporationKangjian Medical Apparatus Co. Ltd.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Serum Separator Tubes Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Serum Separator Tubes Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Serum Replacement Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportSerum Procalcitonin Market
Market size, share, segmentation and regional forecast.
$533M market · 2025 base year
View reportSerum Pregnancy Test Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportSerum Medium Bottle Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportSerum Lactate Testing Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportSerum Glass Vials Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportSerum Freezing Culture Media Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportSerum Free Stem Cell Medium Market
Market size, share, segmentation and regional forecast.
$876M market · 2025 base year
View reportSerum Free & Specialty Media Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportSerum-free medium (SFM) for CHO Culture Market
Market size, share, segmentation and regional forecast.
$835M market · 2025 base year
View reportSerum-Free Medium Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportSerum-free Medium for Cells Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.